Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT reports. © 2024 TechCrunch. All rights reserved. For personal use only.
A delicious smell of baking fills the air, making its way down the street in a semi-industrial area of Kilifi County on the Kenyan coast. Francis Thoya is busy baking his fish cookies. “I wanted to ...